Spero Therapeutics (SPRO) Receivables (2022 - 2026)
Spero Therapeutics' Receivables came in at $44,000 for Q1 2026, down 99.8% from $24.28 million a year earlier and down 99.8% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Receivables (2022 - 2026) Analysis & Trends
At the end of FY2025, Spero Therapeutics' Receivables was $25.39 million, down 51.6% from FY2024.
- Receivables carries a three-year compound annual growth rate of 186.1% (FY2022 to FY2025).
- Going back by year, Receivables was $52.48 million in FY2024 (+3.5%), $50.7 million in FY2023 and $1.08 million in FY2022.
- The Q1 2026 figure represents the lowest quarterly Receivables in data going back to Q4 2022.
- Year-over-year, Receivables has declined for five consecutive quarters, with an average decline of 58.3% over the last six quarters.
- Business Quant data shows SPRO's Receivables at $25.39 million (Q4 2025), $2.46 million (Q3 2025) and $26.91 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 25.39 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 26.91 Mn |
| Mar 31, 2025 | 24.28 Mn |
| Dec 31, 2024 | 52.48 Mn |
| Sep 30, 2024 | 53.28 Mn |
| Jun 30, 2024 | 55.50 Mn |
| Mar 31, 2024 | 54.22 Mn |
| Dec 31, 2023 | 50.70 Mn |
| Dec 31, 2022 | 1.08 Mn |
API Access
Spero Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();